Skip main navigation
start main content

Medications & Therapies

Menu

CFP Logo
For your CF Medication needs
For your CF Medication needs

Cystic Fibrosis Services offers the convenience of easy access to a wide variety of CF medications—including limited-distribution drugs and medical devices—all in one place!1


We carry a wide variety of CF medications

KALYDECO (kuh-LYE-deh-koh) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated for the treatment of cystic fibrosis (CF) in patients age 2 years and older who have one of the following mutations in their CFTR gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, or S549R. KALYDECO is used for the treatment of CF in patients age 2 years and older who have an R117H mutation in their CFTR gene. KALYDECO is not effective in CF patients with two copies of the F508del mutation (F508del/F508del) in the CFTR gene. Safety and effectiveness have not been established in children under 2 years of age.

KALYDECO Drug Information

CAYSTON is a monobactam antibacterial indicated to improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa. Safety and effectiveness have not been established in pediatric patients below the age of 7 years, patients with FEV1 <25% or <75% predicted, or patients colonized with Burkholderia cepacia.

CAYSTON Drug Information

ORKAMBI is a combination of lumacaftor and ivacaftor, a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated for the treatment of cystic fibrosis (CF) in patients age 12 years and older who are homozygous for the F508del mutation in the CFTR gene. If the patient's genotype is unknown, an FDA-cleared CF mutation test should be used to detect the presence of the F508del mutation on both alleles of the CFTR gene. The efficacy and safety of ORKAMBI have not been established in patients with CF other than those homozygous for the F508del mutation.

ORKAMBI Drug Information

CREON is a combination of porcine-derived lipases, proteases, and amylases used to treat patients who cannot digest food normally because their pancreas does not make enough enzymes due to cystic fibrosis or other conditions. CREON is not interchangeable with any other enzyme product.

CREON Drug Information

PANCREAZE is a combination of porcine-derived lipases, proteases, and amylases used to treat patients who cannot digest food normally because their pancreas does not make enough enzymes due to cystic fibrosis or other conditions. PANCREAZE is not interchangeable with any other enzyme product.

PANCREAZE Drug Information

PERTZYE is a combination of porcine-derived lipases, proteases, and amylases used to treat patients who cannot digest food normally because their pancreas does not make enough enzymes due to cystic fibrosis or other conditions. Use of PERTZYE in children is limited by the available capsule dosage strengths and their ability to provide the recommended dose based on age and weight. PERTZYE is not interchangeable with any other enzyme product.

Pertzye Drug Information

ULTRESA is a combination of porcine-derived lipases, proteases, and amylases used to treat patients who cannot digest food normally because their pancreas does not make enough enzymes due to cystic fibrosis or other conditions. ULTRESA is not interchangeable with any other enzyme product.

ULTRESA Drug Information

VIOKASE tablets is a combination of porcine-derived lipases, proteases, and amylases used to treat patients who cannot digest food normally because their pancreas does not make enough enzymes due to cystic fibrosis or other conditions. VIOKASE is used in combination with a proton pump inhibitor. VIOKASE is not interchangeable with any other enzyme product.

VIOKACE Drug Information

ZENPEP is a combination of porcine-derived lipases, proteases, and amylases used to treat patients who cannot digest food normally because their pancreas does not make enough enzymes due to cystic fibrosis or other conditions. ZENPEP is not interchangeable with any other enzyme product.

ZENPEP Drug Information

PULMOZYME is a recombinant DNase enzyme administered via a nebulizer that's indicated for daily administration in conjunction with standard therapies for the management of cystic fibrosis (CF) patients to improve pulmonary function.

Pulmozyme Drug Information

BETHKIS is an inhaled aminoglycoside antibacterial indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of six years, patients with a forced expiratory volume in 1 second (FEV1) less than 40% or greater than 80% predicted, or patients colonized with Burkholderia cepacia.

BETHKIS Drug Information

TOBI is an antibacterial aminoglycoside indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in 1 second (FEV1) <25% or >75% predicted, or patients colonized with Burkholderia cepacia.

TOBI Drug Information

TOBI Podhaler is an antibacterial aminoglycoside indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in 1 second (FEV1) <25% or >80%, or patients colonized with Burkholderia cepacia.

TOBI Podhaler Drug Information

We carry PARI Respiratory Equipment, Inc. nebulizers, replacement filters, aerosol masks and Kitabis Pak(a co-packaging of tobramycin inhalation solution and PARI LC PLUS Reusable Nebulizer). Kitabis Pak is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with FEV1 <25% or >75% predicted, or patients colonized with Burkholderia cepacia.

Kitabis Pak Drug Information

Vitamax multivitamins are vitamins in a water-miscible form made specifically for individuals who cannot absorb these vitamins in their normal fat-soluble form.2

Sodium chloride inhalation is used as a expectorant to produce mucus or phlegm to improve lung function in individuals with CF. Sodium chloride is also used to dilute nebulized medications.

Generic Sodium Chloride Drug Information

Insulin for CF-related diabetes

HUMALOG is a rapid-acting insulin that provides coverage for carbohydrates in meals and snacks. Humalog may be taken 5 to 15 minutes prior to eating and starts working in about 15 to 25 minutes with effects lasting 3 to 5 hours. Humalog can be used in insulin pumps.

HUMALOG Drug Information

NOVOLOG is a rapid-acting insulin that provides coverage for carbohydrates in meals and snacks. NovoLog may be taken 5 to 15 minutes prior to eating and starts working in about 15 to 25 minutes with effects lasting 3 to 5 hours. NovoLog can be used in insulin pumps.

NOVOLOG Drug Information

APIDRA is a rapid-acting insulin that provides coverage for carbohydrates in meals and snacks. Apidra may be taken 5 to 15 minutes prior to eating and starts working in about 15 to 25 minutes with effects lasting 3 to 5 hours. Apidra can be used in insulin pumps.

APIDRA Drug Information

HUMULIN R is a short-acting insulin that provides coverage for carbohydrates in meals. Humulin is taken 30 minutes prior to eating and starts working in about 30 to 60 minutes with effects lasting 6 to 8 hours Humulin may also be used to cover for tube feedings.

HUMULIN R Drug Information

NOVOLIN R is a short-acting insulin that provides coverage for carbohydrates in meals. Novolin is taken 30 minutes prior to eating and starts working in about 30 to 60 minutes with effects lasting 6 to 8 hours. Novolin may also be used to cover for tube feedings.

NOVOLIN R Drug Information

HUMULIN N is an intermediate-acting insulin that also provides coverage for carbohydrates in meals. Humulin N is taken 45 to 60 minutes prior to eating and starts working in about 60 to 90 minutes with effects lasting 12 to 18 hours. Humulin N may also be used to cover for tube feedings.

HUMULIN N Drug Information

NOVOLIN N is an intermediate-acting insulin that also provides coverage for carbohydrates in meals. Novolin N is taken 45 to 60 minutes prior to eating and starts working in about 60 to 90 minutes with effects lasting 12 to 18 hours. Novolin N may also be used to cover for tube feedings.

NOVOLIN N Drug Information

LANTUS is a long-acting or basal insulin that provides a constant amount of insulin over 24 hours. Lantus gives the body the insulin it needs when you're not eating, but it is not strong enough to cover for meals. Lantus can be taken once daily at any time of the day, as long as it is at the same time every day. Long-acting insulin may also need to be given for meals and snacks.

LANTUS Drug Information

LEVEMIR is a long-acting or basal insulin that provides a constant amount of insulin over 24 hours. Levemir gives the body the insulin it needs when you're not eating, but it is not strong enough to cover for meals. Levemir can be taken once daily at any time of the day, as long as it is at the same time every day. Long-acting insulin may also need to be given for meals and snacks.

LEVEMIR Drug Information

Medications and therapies for CF-related organ transplants

CELLCEPT (mycophenolate mofetil) is an anti-metabolite indicated for the prophylaxis of organ rejection in patients receiving organ transplants. CellCept is used in conjunction with other immunosuppressant medications as indicated. It is available as a tablet, capsule and oral suspension.

CELLCEPT Drug Information

MYFORTIC (mycophenolic acid) is an anti-metabolite indicated for the prophylaxis of organ rejection in combination with other immunosuppressant medications as indicated. Myfortic is approved for patients 5 years of age and older.

MYFORTIC Drug Information

NEORAL (cyclosporine modified) is a calcineurin inhibitor indicated for the prophylaxis of organ rejection. Neoral is used in combination with other immunosuppressant medications as indicated. Routine monitoring of cyclosporine modified blood concentration is also indicated. Neoral is available in a soft gelatin capsule and oral solution.

NEORAL Drug Information

RAPAMUNE (sirolimus) is an mTOR-inhibitor indicated for the prophylaxis of organ rejection in patients receiving organ transplants and is used in combination with other immunosuppressant medications as indicated. Therapeutic drug monitoring is recommended for all patients. Rapamune is available as a tablet and oral solution.

RAPAMUNE Drug Information

PROGRAF (tacrolimus) is a calcineurin inhibitor indicated for the prophylaxis of organ rejection in patients receiving organ transplants. Prograf is used in combination with other immunosuppressant medications as indicated. Therapeutic drug monitoring is recommended for all patients. Prograf is available as a capsule.

PROGRAF Drug Information

ZORTRESS (everolimus) is an mTOR-inhibitor indicated for the prophylaxis of organ rejection in adult patients 18 years of age and older. Zortress is used in combination with other immunosuppressant medications as indicated. Therapeutic drug monitoring is recommended for all patients. Zortress is available as a tablet.

ZORTRESS Drug Information

1 Limited-distribution drugs may have special dosing and monitoring requirements that need to be followed closely. Only a select group of pharmacies with specialized expertise are designated as providers. CF Services is a designated provider for Bethkis, Kalydeco, TOBI and TOBI Podhaler and the eRapid Nebulizer System.

2 Vitamax information is provided by the manufacturer. Keep out of reach of children. As with any supplement, consult your doctor before use.

This content is provided as a service of Walgreens. Ask your physician if a treatment is right for you. Please see the full prescribing information for drug information, available at dailymed.nlm.nih.gov. Speak with your physician for information about the risks and benefits of available treatments. Brand names are the property of their respective owners.

omnitureLink1